Firomu® is the brand name developed by Maruho. It belongs to oral penem antibacterial agents. It inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins, exerting bactericidal activity against a broad spectrum of aerobic and anaerobic gram-positive and gram-negative pathogens.
Main Indications
For the treatment of mild to moderate bacterial infections caused by susceptible strains, including otitis media, sinusitis, pharyngitis, tonsillitis, and pneumonia in pediatric patients.
Clinical Research
Japanese phase 2 and phase 3 clinical trials confirmed that faropenem sodium granules achieve satisfactory clinical cure rates for paediatric respiratory tract and otorhinolaryngological bacterial infections. It shows good oral absorption and favourable safety profile in children. Domestic clinical trials in China verified its efficacy and tolerability for local paediatric population.
Common Side Effects
Systemic reactions: diarrhoea, loose stools;
Common mild adverse reactions: nausea, rash, elevated liver enzymes. Rare serious adverse events: severe hypersensitivity, pseudomembranous colitis.
Approval Status in China
This imported original drug, marketed under brand name Firomu® (Chinese name: Feiruomu), was officially approved for marketing in China in 2010, with the specification of 0.05g, 3 sachets per box. It is currently a prescription antibacterial drug.
Buy Firomu (Pediatric Faropenem Sodium Granules) online from China and save up to 80% on costs . no insurance needed . compare prices from a certified HongKong pharmacy .with fast shipping. Contact us now on WhatsApp to get the latest prices.
